Care of 217 Spire patients reviewed amid surgeon probe

A private hospital is looking into operations carried out by a doctor it has stopped from practising.

Share Button

Health24.com | New hope against a ‘dizzying’ form of migraine

People who suffer bouts of vertigo and dizziness may be suffering from a type of migraine for which treatments rarely work.

But a new, preliminary study of 18 such patients found that stimulating the vagus nerve in the neck can help relieve vertigo.

Off balance and nauseous

“Vestibular migraine can occur with or without headache. It’s an uncomfortable feeling, an abnormal sense of motion. A lot of people say that they feel like they’re spinning,” explained Dr Deena Kuruvilla, an assistant professor of neurology at Yale University.

Patients feel like they’re off balance and may be nauseous. “It’s an incredibly disabling disorder,” said Kuruvilla, who was not involved in the study.

It’s a tricky condition to diagnose, she added. “Nine times out of 10, patients get misdiagnosed,” so people are best off seeing a neurologist or a headache specialist, Kuruvilla said.

However, the new treatment might help ease the condition, the authors of the new study said.

“Noninvasive vagus nerve stimulation that’s approved for migraines and cluster headaches also relieves vertigo in patients with vestibular migraine,” said lead researcher Dr Shin Beh. He’s an assistant professor of neurology at the University of Texas Southwestern Medical Center, in Dallas.

Stimulating the vagus nerve appears to calm down centres in the brain that cause migraine and vertigo, he explained.

Less pain after treatment

Vestibular migraine is not curable, Beh said, “but this adds another possible treatment.”

The stimulation is delivered via a handheld device placed against the neck during a vestibular migraine attack. The device that delivers electrical impulses to the nerve is regularly used to treat typical migraines.

Among the study participants, 14 patients were treated during a vestibular migraine attack, and four patients were treated for persistent dizziness between attacks.

After the nerve stimulation, 13 of the 14 patients had an improvement in their vertigo. In this group, two had their vertigo disappear and five experienced a 50% reduction in symptoms, the researchers found.

In addition, the five patients whose attack had an associated headache all reported less pain after the treatment.

How long the effect of the nerve stimulation lasts isn’t known, Beh said. The study wasn’t designed to see if nerve stimulation prevents future attacks.

It’s also possible that the effect could be heightened if it’s used in combination with migraine medications, he suggested.

Prohibitive cost

Unfortunately, none of the patients treated for persistent dizziness between attacks experienced any improvement.

The only discomfort from the treatment was a mild pulling sensation of the neck muscles, the researchers noted.

The study is limited by its small size and the fact that all of the patients received the real treatment, so the results can’t be compared with people given sham treatment, Beh said.

The findings were published online in the journal Neurology.

Kuruvilla said, “I don’t think the study had enough people in it to draw such a dramatic conclusion to say that each of these vertigo attacks, these dizziness attacks, are going to be completely cured with this device.”

Another drawback is the cost of the device. “The monthly cost that the company has put on the device has made it really prohibitive for the majority of people,” she added.

According to Kuruvilla, the monthly fees can run as high as $600 (±R8 600), and the treatment isn’t covered by insurance.

Image credit: iStock

Share Button

Health24.com | Why many children with autism have oral health problems

The World Health Organisation estimates that 1 in 160 children around the world has an autism spectrum disorder. Autism is a condition related to the development of the brain and is usually noticeable by the time a child is three years old. Statistics aren’t available for any African country, so researchers like me in South Africa are using international prevalence rates.

Children with this neurodevelopmental disorder may have difficulty learning language and interacting with people.

Having autism does not mean that a child’s teeth and other facial features will be different. But these children are likely to develop oral health problems for a number of reasons such as unusual oral habits, medications and poor food choices. Difficult behaviours can also contribute to oral problems. These behaviours include head banging, picking at the lips, removing their tooth buds and chewing on harmful objects like stones. These children also prefer soft foods which they tend to pouch at the back of their mouths for long periods of time.

We conducted the first study in South Africa that looks into the oral health of children with autism. We examined children attending special needs schools in KwaZulu-Natal province.

Most of the children had cavities in their permanent teeth. The percentage of children with cavities was higher than the national average. This means that there is a great burden of dental caries or tooth decay for children with autism in South Africa. The decayed teeth recorded in both the permanent and primary teeth in this study were all untreated, meaning the children’s dental needs are not being met.

What we found

In 2017, we examined children between the ages of 7 and 14. We checked them for decayed, missing and filled teeth, inflammation of the gums and the presence of plaque as well as attrition and soft tissue trauma using the World Oral Health Survey Form for Children. We also asked the children’s parents to complete a questionnaire.

We found mild swelling of the gums in 43.6% of the children; evidence of fair oral hygiene practices was observed in 42.3% and mild grinding of the teeth in 47% of the children we examined. Responses from the parent questionnaire indicated that most children prefer carbohydrates, and a combination of carbohydrates and proteins. More than half (52.9%) of the children only brushed their teeth once a day. Lip biting (56.3%) was the most prevalent soft tissue trauma observed.

We found that 85.2% of the children had cavities in their permanent teeth. This rate was higher than figures from National Oral Health surveys which indicated a caries prevalence in the general population of children of 41.7% in 2002; prevalence of 55% and 56.5% was reported in 2014 and 2015 respectively.

The decayed teeth were all untreated. Unmet dental needs in the South African context are not limited to children with disabilities. They may be as a result of factors such as financial costs of dental care and poor medical insurance coverage.

In addition, the medication consumed by children with autism can also affect their gum health. Almost 45% of children and adolescents with autism use medications whose side effects have dental implications. The side effects include dry mouth, overgrown gums, toothache, changes in salivation, prolonged bleeding and altered taste.

The medications may also cause motor disturbances that may affect efficient oral care practices. Grinding of the teeth, resulting in wearing down of the tooth structure, has also been noted often in these children.

Way forward

The need for oral hygiene programmes at special needs schools is highly recommended to increase awareness and improve oral care.

Changes to oral care practices by conducting oral health programmes to educate parents and caregivers of children with autism spectrum disorder is also necessary. A structured programme for the autism spectrum disorder population at school and community level would help.

For example, the Sparkle Brush Programme was successfully introduced in four special needs schools in KwaZulu-Natal and the Western Cape. The programme is part of a collaborative community engagement initiative between the University of KwaZulu-Natal and University of the Western Cape.

This programme had two phases. Phase 1 was a full training programme for the special needs teachers, teaching assistants and nurses. Phase 2 was the demonstration of tooth brushing, hand washing and healthy eating to the children with special needs. A monthly courtesy visit and a six monthly recall visit has been scheduled with these schools.

This programme was awarded the International Social Responsibility Award for Special Needs in Brisbane in August 2019. It was presented at the International Social Responsibility conference in Brisbane, where 33 countries participated. South Africa was awarded the best social responsibility programme for special needs.The Conversation

Magandhree Naidoo, Senior Lecturer Department of Oral Hygiene, University of the Western Cape

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Share Button

Tired of walking alone? Team up!

Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.

Advertising & Sponsorship

Mayo Clinic Marketplace

Check out these best-sellers and special offers on books and newsletters from Mayo Clinic.

Share Button

Novel Coronavirus that recently emerged in China

The new cluster of viral pneumonia cases originating in Wuhan, China, marks the third time in 20 years that a member of the large family of coronaviruses (CoVs) has jumped from animals to humans and sparked an outbreak. In a new JAMA Viewpoint essay, Anthony S. Fauci, M.D., director of the NIH’s National Institute of Allergy and Infectious Diseases (NIAID), looks back at two earlier novel CoV outbreaks that initially caused global havoc and describes steps needed to contain the current one.

Dr. Fauci and his co-authors, Hilary D. Marston, M.D., M.P.H., of NIAID, and Catharine I. Paules, M.D., of Penn State University College of Medicine, note that human CoVs historically have been regarded as relatively benign causes of the common cold. In 2002, however, a novel, highly pathogenic CoV emerged in China that caused 8,098 recorded cases of severe acute respiratory syndrome (SARS), including 774 deaths, and cost the global economy billions of dollars. Classic public health measures brought the outbreak to an end.

Another CoV jumped from animals to humans in 2012 to cause of Middle East respiratory syndrome (MERS). Unlike SARS-CoV, which has not caused additional human cases since being eliminated within several months of the initial outbreak, MERS-CoV continues to smolder due to sporadic transmission from camels — the virus’s intermediate host — to people, and limited chains of person-to-person transmission.

The latest CoV to emerge is the 2019 novel coronavirus (2019-nCoV), recognized by Chinese authorities in Wuhan on December 31, 2019. It has spread beyond Wuhan to other Chinese cities and to multiple countries, including at least one confirmed case in the United States. The Viewpoint authors write, “While the trajectory of this outbreak is impossible to predict, effective response requires prompt action from the standpoint of classic public health strategies to the timely development and implementation of effective countermeasures.”

Current studies at NIAID-funded institutions and by scientists in NIAID laboratories include efforts that build on previous work on SARS- and MERS-CoVs. For example, researchers are developing diagnostic tests to rapidly detect 2019-nCoV infection and exploring the use of broad-spectrum anti-viral drugs to treat 2019-nCoVs, the authors note. NIAID researchers also are adapting approaches used with investigational SARS and MERS vaccines to jumpstart candidate vaccine development for 2019-nCoV. Advances in technology since the SARS outbreak have greatly compressed the vaccine development timeline, the authors write. They indicate that a candidate vaccine for 2019-nCoV could be ready for early-stage human testing in as little as three months as compared to 20 months for early-stage development of an investigational SARS vaccine.

The authors conclude that, “the emergence of yet another outbreak of human disease caused by a pathogen from a viral family formerly thought to be relatively benign underscores the perpetual challenge of emerging infectious diseases and the importance of sustained preparedness.”

Story Source:

Materials provided by NIH/National Institute of Allergy and Infectious Diseases. Note: Content may be edited for style and length.

Share Button

Mystery of Grand Canyon’s water supply

We all know the Colorado River, but it’s not the most mysterious water resource in the Grand Canyon; we know it moves through at a rate of about 12,000 cubic feet per second as it travels from the Rocky Mountains to the Gulf of California. But Roaring Springs, Grand Canyon National Park’s only water source, is a bigger mystery — one NAU researcher Natalie Jones hopes to have a hand in solving.

Jones, an NAU research technician and graduate student contracted by the Grand Canyon Physical Sciences program, asked where the water in Roaring Springs comes from in research she did with School of Earth and Sustainability professor Abe Springer. It’s building on previous research for both of them. They published their findings in November in Hydrogeology Journal, with Jones as the lead author and in collaboration with researchers at the Grand Canyon National Park, Nez Perce-Clearwater National Forests and the Kentucky Geological Survey at the University of Kentucky.

So, where does the water come from? It’s complicated. But this research helps to pinpoint the region feeding the springs and, importantly, the risk of contamination in that region. It takes researchers one step closer to understanding how to protect this vital resource.

Jones and her co-authors set out to investigate how to create a better way to model karst-aquifer vulnerability in the Grand Canyon. Having a model that more accurately predicts different variables in the geology and water behavior in the park will benefit future researchers and water managers as they consider individual recharge areas and how best to protect them.

What is karst and why does it matter?

Did you know water can sometimes dissolve rock? Karst is a type of rocky feature such as a cave or sinkhole that forms in dissolvable rocks. Karst creates pathways that can carry water quickly from the land surface directly to underground aquifers. Karst landscapes cover about 16 percent of the Earth’s land surface, including most of the Colorado Plateau around Flagstaff and the Grand Canyon. It’s an important geologic feature that most of us have never heard of.

Karst aquifers, which have a pipe-like flow network of caves and conduits, directly supply up to 25 percent of the world population with water for drinking, agriculture and other needs and they are uniquely vulnerable to contamination. Two such aquifers, the Redwall and Coconino aquifers, supply water to Roaring Springs and many other Grand Canyon springs. The two aquifers are stacked on top of each other. While there are many types of vulnerability models, most ignore the complication of layered karst aquifer systems; this results in oversimplified, less accurate modeling.

“Vulnerability models identify regions of high, moderate and low vulnerability on the land surface, which directly relates to how quickly and efficiently water or contaminants would sink and enter the aquifer,” Jones said. “However, existing well-regarded vulnerability modeling methods for karst aquifers did not produce realistic results for our region.”

How does the modeling work?

Jones modified the well-known concentration-overburden-precipitation method (COP). This method is effective, the researchers say, but it oversimplifies some details, which limits the model. She presented two new models that better address the factors that help scientists predict vulnerability.

The modifications more accurately account for recharge patterns in the Grand Canyon region, which has many karst features and a deep, complex aquifer system. Jones and the research team automated a process to identify sinkholes from high-resolution topography data, converted those data into sinkhole densities, and combined those data with a map of fault locations in the region. Jones then incorporated these features into the existing model using a geographic information system to produce the final vulnerability model.

It meant significant data processing, but the result was a model that produced greater resolution of vulnerability regions and fit well with previous groundwater flow path analyses. In addition to creating a better model on which future research can build, Jones found similar patterns in vulnerability between the two karst aquifers in the Grand Canyon region, despite them being separated by more than 600 meters of impermeable rock.

Jones also learned that about a fifth of the Kaibab Plateau has high vulnerability to contamination of the Redwall-Muav aquifer, which is about 1,000 meters deep, and almost half of the plateau surface (45.6 percent) has high to very high vulnerability for the Coconino aquifer, which is much closer to the surface.

What does this mean for me?

If you’ve stopped to fill your water bottle while you’re hiking the Grand Canyon or admiring the views on the canyon rim, this matters to you. Since the Roaring Springs is the only source of water in the park, its quality has significant value. This research provides better information to water managers to protect the Grand Canyon’s water resources, including creeks on the north side, which researchers think are recharged by the Kaibab Plateau.

“These springs and streams support diverse ecosystems, and many hikers and wildlife rely on them for survival,” Jones said. “This research helps narrow down where these water sources are coming from and could help us better protect them in the future.”

Share Button

Living near major roads linked to risk of dementia, Parkinson’s, Alzheimer’s and MS

Living near major roads or highways is linked to higher incidence of dementia, Parkinson’s disease, Alzheimer’s disease and multiple sclerosis (MS), suggests new research published this week in the journal Environmental Health.

Researchers from the University of British Columbia analyzed data for 678,000 adults in Metro Vancouver. They found that living less than 50 metres from a major road or less than 150 metres from a highway is associated with a higher risk of developing dementia, Parkinson’s, Alzheimer’s and MS — likely due to increased exposure to air pollution.

The researchers also found that living near green spaces, like parks, has protective effects against developing these neurological disorders.

“For the first time, we have confirmed a link between air pollution and traffic proximity with a higher risk of dementia, Parkinson’s, Alzheimer’s and MS at the population level,” says Weiran Yuchi, the study’s lead author and a PhD candidate in the UBC school of population and public health. “The good news is that green spaces appear to have some protective effects in reducing the risk of developing one or more of these disorders. More research is needed, but our findings do suggest that urban planning efforts to increase accessibility to green spaces and to reduce motor vehicle traffic would be beneficial for neurological health.”

Neurological disorders — a term that describes a range of disorders, including Alzheimer’s disease and other dementias, Parkinson’s disease, multiple sclerosis and motor neuron diseases — are increasingly recognized as one of the leading causes of death and disability worldwide. Little is known about the risk factors associated with neurological disorders, the majority of which are incurable and typically worsen over time.

For the study, researchers analyzed data for 678,000 adults between the ages of 45 and 84 who lived in Metro Vancouver from 1994 to 1998 and during a follow-up period from 1999 to 2003. They estimated individual exposures to road proximity, air pollution, noise and greenness at each person’s residence using postal code data. During the follow-up period, the researchers identified 13,170 cases of non-Alzheimer’s dementia, 4,201 cases of Parkinson’s disease, 1,277 cases of Alzheimer’s disease and 658 cases of MS.

For non-Alzheimer’s dementia and Parkinson’s disease specifically, living near major roads or a highway was associated with 14 per cent and seven per cent increased risk of both conditions, respectively. Due to relatively low numbers of Alzheimer’s and MS cases in Metro Vancouver compared to non-Alzheimer’s dementia and Parkinson’s disease, the researchers did not identify associations between air pollution and increased risk of these two disorders. However, they are now analyzing Canada-wide data and are hopeful the larger dataset will provide more information on the effects of air pollution on Alzheimer’s disease and MS.

When the researchers accounted for green space, they found the effect of air pollution on the neurological disorders was mitigated. The researchers suggest that this protective effect could be due to several factors.

“For people who are exposed to a higher level of green space, they are more likely to be physically active and may also have more social interactions,” said Michael Brauer, the study’s senior author and professor in the UBC school of population and public health. “There may even be benefits from just the visual aspects of vegetation.”

Brauer added that the findings underscore the importance for city planners to ensure they incorporate greenery and parks when planning and developing residential neighbourhoods.

The study was co-authored by Hind Sbihi, Hugh Davies, and Lillian Tamburic in the UBC school of population and public health.

Story Source:

Materials provided by University of British Columbia. Note: Content may be edited for style and length.

Share Button

Health24.com | Using marijuana to help with sleep? Benefits may not last

Medical marijuana may not provide long-term relief of sleep issues in people battling chronic pain, a new study finds, mainly because users may develop a tolerance to the drug.

The finding is important “considering the ageing of the population, the relatively high prevalence of sleep problems in this population, along with the increasing use of medicinal cannabis,” said an Israeli team led by Sharon Sznitman, from the School of Public Health at the University of Haifa.

Various sleep issues

According to the study authors, chronic pain affects between 19% to 37% of adults in the developed world, many who have sleep problems.

Some are turning to medical marijuana for help getting good shut-eye. But how well does it work?

To find out, Sznitman’s group assessed sleep and pain in 128 patients who’d had chronic pain for at least a year. All were over age 50 and about half (66) said they used medical marijuana to help manage their sleep problems.

The type of sleep issues varied: About one in four patients said they always woke up early and weren’t able to get back to sleep; one in five said they always had difficulty falling asleep, and 27% said they woke up during the night.

Of the patients who used marijuana, average duration of use was four years, using an average of 31 grams of the drug per month. Most (69%) said they smoked marijuana, and about one in five used either cannabis oil or vapour.

A downside

The study found that pot users were less likely to wake during the night, but there were no differences between users and nonusers in the time it took them get to sleep or in the frequency of early awakening.

And there seemed to be a downside: The researchers found that more frequent marijuana use was associated with greater difficulty in falling asleep, plus more frequent awakenings during the night.

“This may signal the development of tolerance,” Sznitman’s team wrote.

But the study couldn’t prove cause-and-effect, so other factors might be at play. For example, the authors said that more frequent pot use might simply be an indicator that these people were in more pain or might be depressed/anxious. That might explain these participants’ higher propensity for sleep problems.

One US sleep medicine expert said that for some patients with chronic pain, medical marijuana can offer “some hope”.

The new study is far from conclusive as to the drug’s benefits or risks, said Dr Margarita Oks, attending physician in pulmonary, critical care and sleep medicine at Lenox Hill Hospital in New York City.

Doesn’t reduce cancer pain

“There was no mention of the exclusion of sleep-related disorders, such as obstructive sleep apnoea, that can manifest with insomnia,” she said, “and this may be a huge confounder.”

And Oks said the fact that the study was done in Israel makes a difference, too.

In Israel, “cannabis is legalised and therefore concentrations of THC [the ingredient in marijuana that produces a high] can be objectively and reproducibly measured,” she explained. “In the United States this is not yet the case.”

A second study in the same issue of the journal concluded that cannabinoids (the active chemicals in medical marijuana) do not reduce cancer-related pain. This review pooled the results of five different studies involving more than 1 400 cancer patients. It was led by Dr. Jason Boland of the University of Hull in England.

Both studies were published in the journal BMJ Supportive & Palliative Care.

Image credit: iStock

Share Button

NHS manager gloated over coverage of care home death

A mental health trust claims it “got away with it again” over news coverage of a woman’s death.

Share Button

China coronavirus: ‘Increased likelihood’ of cases in the UK

Six people are being tested in hospitals in Scotland and Northern Ireland after showing symptoms.

Share Button